These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37517767)

  • 1. Amide proton transfer weighted MRI in differential diagnosis of ovarian masses with cystic components: A preliminary study.
    Yu Y; Song X; Zeng Z; Wang L; Zhang L; Zhao H; Zheng Z
    Magn Reson Imaging; 2023 Nov; 103():216-223. PubMed ID: 37517767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
    Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
    Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
    Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
    Eur Radiol; 2024 Oct; 34(10):6820-6830. PubMed ID: 38491129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging.
    Xu Y; Wan Q; Ren X; Jiang Y; Wang F; Yao J; Wu P; Shen A; Wang P
    Magn Reson Imaging; 2024 Feb; 106():104-109. PubMed ID: 38135260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ovarian endometriotic cysts in cystic lesions of the ovary by amide proton transfer-weighted imaging and R2∗ mapping.
    Li Y; Lu X; Chen L; Zhang Q; Wang N; Wang J; Lin L; Hu G; Zhang Y; Liu A
    Clin Radiol; 2023 Feb; 78(2):e106-e112. PubMed ID: 36334944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive Differentiation of Endometrial Adenocarcinoma from Benign Lesions in the Uterus by Utilization of Amide Proton Transfer-Weighted MRI.
    Li Y; Lin CY; Qi YF; Wang XQ; Chen B; Zhou HL; Ren J; Yang JJ; Xiang Y; He YL; Xue HD; Jin ZY
    Mol Imaging Biol; 2021 Jun; 23(3):446-455. PubMed ID: 33185840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Amide Proton Transfer-Weighted Imaging at 3T for Renal Masses: A Preliminary Study.
    Xu Y; Wan Q; Ren X; Jiang Y; Yao J; Wu P; Shen A; Wang P
    Curr Med Imaging; 2024; 20():e15734056284650. PubMed ID: 38591213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging.
    Zhang N; Kang J; Wang H; Liu A; Miao Y; Ma X; Song Q; Zhang L; Wang J; Shen Z; Xu X
    Clin Imaging; 2022 Jan; 81():15-23. PubMed ID: 34597999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional turbo-spin-echo amide proton transfer-weighted mri for cervical cancer: A preliminary study.
    He YL; Li Y; Lin CY; Qi YF; Wang X; Zhou HL; Yang JJ; Xiang Y; Xue HD; Jin ZY
    J Magn Reson Imaging; 2019 Oct; 50(4):1318-1325. PubMed ID: 30859696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Kirsten rat sarcoma (
    Yang X; Qiu Q; Lu W; Chen B; Zhao M; Liang W; Wen Z
    Quant Imaging Med Surg; 2024 Oct; 14(10):7061-7072. PubMed ID: 39429593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma: a preliminary study.
    Chen W; Liu G; Chen J; Wei Q; Ye Y; Du X; Feng J; Yan Z; Deng K; Liu X
    Eur Radiol; 2023 Jul; 33(7):5159-5171. PubMed ID: 36700956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
    Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
    Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion MR imaging for type I endometrial carcinoma: Correlation with Ki-67 proliferation status.
    Li Y; Lin CY; Qi YF; Wang X; Chen B; Zhou HL; Ren J; Yang JJ; Xiang Y; He YL; Xue HD; Jin ZY
    Magn Reson Imaging; 2021 May; 78():18-24. PubMed ID: 33556484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging.
    Chen W; Li L; Yan Z; Hu S; Feng J; Liu G; Liu B; Liu X
    Eur Radiol; 2021 May; 31(5):3286-3296. PubMed ID: 33125558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
    Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional amide proton transfer-weighted and intravoxel incoherent motion imaging for predicting bone metastasis in patients with prostate cancer: A pilot study.
    Hu W; Chen L; Lin L; Wang J; Wang N; Liu A
    Magn Reson Imaging; 2023 Feb; 96():8-16. PubMed ID: 36375760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
    Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z
    Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of O-RADS MRI Score in Differentiating Benign From Malignant Ovarian Teratomas: MR Feature Analysis for Differentiating O-RADS 4 From O-RADS 2.
    Petrocelli R; Doshi A; Slywotzky C; Savino M; Melamud K; Tong A; Hindman N
    J Comput Assist Tomogr; 2024 Sep-Oct 01; 48(5):749-758. PubMed ID: 38968317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.